Virtual Medicinal Product (VMP)
-
Testosterone 100mg implant
Name Details
Current Name
Testosterone 100mg implant
|
Start Date
28-01-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- device
- Unit Dose UOM
- device
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Subcutaneous
- Form
- Prolonged-release subcutaneous implant
- Ontology Form/Route
- implant.subcutaneous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03BA03
BNF |
Current BNF
06040200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040200
|
Start Date
24-02-2005
|
End Date
13-01-2015
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41882511000001107 |
26-05-2023 |
|
347317004 |
28-01-2003 |
25-05-2023 |
VMP Ingredients
VMP ingredients table
Testosterone |
Based on Ingredient Substance |
|
100 mg |
|
Name
Testosterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information